A new NICE and RAFT (Regulatory Authority for Fertility and Tissue) to underpin NHS reform
This article was originally published in Clinica
Central to the local delivery of the standards and improvements set out by the UK's Department of Health in last week's White Paper will be the "reconfiguration of the DoH's arm's length bodies" (ALBs), as first outlined last July.
You may also be interested in...
As generalist investors continue to push higher the stock prices of biotech companies that announce the most tenuous of coronavirus developments, the track record of biotech companies developing even vaccines for which the antigen is proven to be safe and efficacious remains poor.
In a bipartisan move, the US Senate is moving to impose new rules on companies - including those from China - seeking US initial public offerings, adding further uncertainty over such plans and further stoking trade tensions.
First-line lung cancer approval will expand potential market for Takeda's ALK contender but the latecomer is also facing some well-established class competition in the setting.